Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Hygiene and Health Care (NSE:PGHH)

Simply Wall St · 1d ago

The market wasn't impressed with the soft earnings from Procter & Gamble Hygiene and Health Care Limited (NSE:PGHH) recently. We did some analysis, and found that there are some reasons to be cautious about the headline numbers.

earnings-and-revenue-history
NSEI:PGHH Earnings and Revenue History November 20th 2026

Examining Cashflow Against Procter & Gamble Hygiene and Health Care's Earnings

One key financial ratio used to measure how well a company converts its profit to free cash flow (FCF) is the accrual ratio. To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. This ratio tells us how much of a company's profit is not backed by free cashflow.

Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.

Over the twelve months to September 2026, Procter & Gamble Hygiene and Health Care recorded an accrual ratio of 0.36. Therefore, we know that it's free cashflow was significantly lower than its statutory profit, raising questions about how useful that profit figure really is. Indeed, in the last twelve months it reported free cash flow of ₹7.2b, which is significantly less than its profit of ₹7.77b. Procter & Gamble Hygiene and Health Care's free cash flow actually declined over the last year, but it may bounce back next year, since free cash flow is often more volatile than accounting profits.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Procter & Gamble Hygiene and Health Care's Profit Performance

As we discussed above, we think Procter & Gamble Hygiene and Health Care's earnings were not supported by free cash flow, which might concern some investors. For this reason, we think that Procter & Gamble Hygiene and Health Care's statutory profits may be a bad guide to its underlying earnings power, and might give investors an overly positive impression of the company. But at least holders can take some solace from the 5.8% per annum growth in EPS for the last three. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. To that end, you should learn about the 2 warning signs we've spotted with Procter & Gamble Hygiene and Health Care (including 1 which is a bit unpleasant).

Today we've zoomed in on a single data point to better understand the nature of Procter & Gamble Hygiene and Health Care's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.